METTL3 and hepatocellular carcinoma: Low expression of the m6A methyltransferase, METTL3, under hypoxia is reported to trigger downregulation of FOXO3, thereby enhancing sorafenib resistance and angiogenic gene expression in HCC through YTHDF1-mediated autophagy, ultimately leading to poor prognosis [202].